Literature DB >> 29377119

Secular changes in the symptom level of clinically diagnosed autism.

Olof Arvidsson1, Christopher Gillberg1, Paul Lichtenstein2, Sebastian Lundström1,3.   

Abstract

BACKGROUND: The prevalence of autism has been reported to have increased worldwide. A decrease over time in the number of autism symptoms required for a clinical autism diagnosis would partly help explain this increase. This study aimed to determine whether the symptom level of clinically diagnosed autism cases below age 13 had changed over time.
METHODS: Parents of Swedish 9-year old twins (n = 28,118) participated in a telephone survey, in which symptoms and dysfunction/suffering related to neurodevelopmental disorders [including autism, but also attention-deficit/hyperactivity disorder (ADHD), Developmental Coordination Disorder (DCD), and Learning Disabilities (LD)] in their children were assessed over a 10-year period. Survey data was merged with the National Patient Register containing clinically registered autism diagnoses (n = 271).
RESULTS: In individuals who had been clinically diagnosed with autism before the age of 13, the symptom score for autism decreased on average 30% over more than a decade in birth cohorts 1992-2002. There was an average decrease of 50% in the autism symptom score from 2004 to 2014 in individuals who were diagnosed with autism at ages 7-12, but there was no decrease in those diagnosed at ages 0-6.
CONCLUSIONS: Over time, considerably fewer autism symptoms seemed to be required for a clinical diagnosis of autism, at least for those diagnosed after the preschool years. The findings add support for the notion that the observed increase in autism diagnoses is, at least partly, the by-product of changes in clinical practice, and flag up the need for working in agreement with best practice guidelines.
© 2018 Association for Child and Adolescent Mental Health.

Entities:  

Keywords:  Neurodevelopmental disorders; autism spectrum disorders; prevalence

Mesh:

Year:  2018        PMID: 29377119     DOI: 10.1111/jcpp.12864

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  22 in total

1.  Time Trends in Diagnostics and Clinical Features of Young Children Referred on Suspicion of Autism: A Population-Based Clinical Cohort Study, 2000-2010.

Authors:  Sara Højslev Avlund; Per Hove Thomsen; Diana Schendel; Meta Jørgensen; Loa Clausen
Journal:  J Autism Dev Disord       Date:  2021-02

2.  Prevalence of Autism Spectrum Disorder in 7-9-Year-Old Children in Denmark, Finland, France and Iceland: A Population-Based Registries Approach Within the ASDEU Project.

Authors:  M Delobel-Ayoub; E Saemundsen; M Gissler; A Ego; I Moilanen; H Ebeling; V Rafnsson; D Klapouszczak; E Thorsteinsson; K M Arnaldsdóttir; B Roge; C Arnaud; D Schendel
Journal:  J Autism Dev Disord       Date:  2020-03

3.  The Neurodiversity Approach(es): What Are They and What Do They Mean for Researchers?

Authors:  Patrick Dwyer
Journal:  Hum Dev       Date:  2022-02-22

4.  Defining in Detail and Evaluating Reliability of DSM-5 Criteria for Autism Spectrum Disorder (ASD) Among Children.

Authors:  C E Rice; L A Carpenter; M J Morrier; C Lord; M DiRienzo; A Boan; C Skowyra; A Fusco; J Baio; A Esler; W Zahorodny; N Hobson; A Mars; A Thurm; S Bishop; L D Wiggins
Journal:  J Autism Dev Disord       Date:  2022-01-04

5.  Prevalence of Autism Spectrum Disorders in Adult Outpatient Psychiatry.

Authors:  Johan Nyrenius; Jonas Eberhard; Mohammad Ghaziuddin; Christopher Gillberg; Eva Billstedt
Journal:  J Autism Dev Disord       Date:  2022-01-06

6.  Etiology of Autism Spectrum Disorders and Autistic Traits Over Time.

Authors:  Mark J Taylor; Mina A Rosenqvist; Henrik Larsson; Christopher Gillberg; Brian M D'Onofrio; Paul Lichtenstein; Sebastian Lundström
Journal:  JAMA Psychiatry       Date:  2020-09-01       Impact factor: 21.596

Review 7.  Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?

Authors:  Nermin Eissa; Adel Sadeq; Astrid Sasse; Bassem Sadek
Journal:  Front Pharmacol       Date:  2020-06-16       Impact factor: 5.810

8.  The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice.

Authors:  Nermin Eissa; Sheikh Azimullah; Petrilla Jayaprakash; Richard L Jayaraj; David Reiner; Shreesh K Ojha; Rami Beiram; Holger Stark; Dorota Łażewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

9.  Autism comorbidities show elevated female-to-male odds ratios and are associated with the age of first autism diagnosis.

Authors:  Eya-Mist Rødgaard; Kristian Jensen; Kamilla Woznica Miskowiak; Laurent Mottron
Journal:  Acta Psychiatr Scand       Date:  2021-07-14       Impact factor: 7.734

Review 10.  Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.

Authors:  Nermin Eissa; Mohammed Al-Houqani; Adel Sadeq; Shreesh K Ojha; Astrid Sasse; Bassem Sadek
Journal:  Front Neurosci       Date:  2018-05-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.